Annual report pursuant to Section 13 and 15(d)

Accumulated Other Comprehensive Income (Loss)

v3.6.0.2
Accumulated Other Comprehensive Income (Loss)
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
For the year ended December 31, 2016, changes in Accumulated other comprehensive income (loss), net of tax, were as follows:
(In thousands)
Foreign
currency translation

Unrealized
gain (loss) in
Accumulated
OCI

Total
Balance at December 31, 2015
$
(21,791
)

$
(746
)

$
(22,537
)
Other comprehensive income (loss) before reclassifications
(4,955
)

(3,810
)

(8,765
)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax


4,293


4,293

Net other comprehensive loss
(4,955
)

483


(4,472
)
Balance at December 31, 2016
$
(26,746
)

$
(263
)

$
(27,009
)

Amounts reclassified from Accumulated other comprehensive income (loss) for the year ended December 31, 2016 includes other-than-temporary impairment charges on our investments in Xenetic, ARNO and RXi as discussed in Note 4. Amounts reclassified for our available for sale investments were based on the specific identification method.

For the year ended December 31, 2015, changes in Accumulated other comprehensive income, net of tax, were as follows:
(In thousands)
Foreign
currency translation
 
Unrealized
gain (loss) in
Accumulated
OCI
 
Total
Balance at December 31, 2014
$
(6,717
)
 
$
(5,675
)
 
$
(12,392
)
Other comprehensive income (loss) before reclassifications
(15,074
)
 
(2,378
)
 
(17,452
)
Amounts reclassified from accumulated other comprehensive income, net of tax

 
7,307

 
7,307

Net other comprehensive loss
(15,074
)
 
4,929

 
(10,145
)
Balance at December 31, 2015
$
(21,791
)
 
$
(746
)
 
$
(22,537
)

Amounts reclassified from Accumulated other comprehensive income (loss) for the year ended December 31, 2015 includes an other-than-temporary impairment charge on our investment in RXi as discussed in Note 4. Amounts reclassified for our available for sale investments were based on the specific identification method.